Assistive Technologies in Neuromuscular Rehabilitation drafted
Program start date | Application deadline |
2023-09-26 | 2023-06-01 |
2024-01-23 | 2023-10-16 |
Program Overview
Overview
LEARNING OUTCOMES/OBJECTIVES
The student should be able to:
eurological conditions
MODULE SESSION DATES
Please email sahp.postgraduate-admin@keele.ac.uk for the confirmed course dates.
Deadline for applications is 2 weeks prior to module start date. Applying before this is recommended as spaces are awarded on a first come first served basis (assuming conditions of offers are met).
Program Outline
Module aims
Module aims
To critically evaluate:
Module content
Pathophysiological basis of common impairments in upper motor neurone problems (e.g. paralysis, weakness and fatigue, contractures and spasticity, motor performance).
The role of assistive technologies in the neurological
euromuscular rehabilitation of muscle structure and function, and optimization of functional performance: Exercise prescription; Therapeutic electrical stimulation; Partial body weight supported exercise; Orthotics in neurological rehabilitation (splinting - static and progressive stretching, casting, and orthotic tuning); Application of technology for the retrain of movement (robotics, virtual reality, targeted motor control, functional electrical stimulation); Critical evaluation of common outcome measures that can be used to assess efficacy of assistive technology (e.g. video based gait analysis, ultrasound for muscle imaging, joint stiffness measurement, and measurement of activity and participation).
Teaching and assessment
Teaching and assessment
TEACHING
Block sessions: Lectures, seminars, discussions, and workshops. The student is expected to complete at least double the amount of self directed study.
ASSESSMENT
Student choice:
Either
Written 4,000 word essay, relating to modular content, in which the student identifies an assistive technology, and evaluates its clinical applicability in relation to maximizing functional potential (with reference to the evidence base)
OR
45 minutes oral presentation of the same to include questions